5-Methyl-8-(beta-D-ribofuranosyl)-5,8-dihydropyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-4-amine

ID: ALA4556165

PubChem CID: 134229916

Max Phase: Preclinical

Molecular Formula: C14H17N5O4

Molecular Weight: 319.32

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1ccc2c1c1c(N)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C14H17N5O4/c1-18-3-2-6-9(18)8-12(15)16-5-17-13(8)19(6)14-11(22)10(21)7(4-20)23-14/h2-3,5,7,10-11,14,20-22H,4H2,1H3,(H2,15,16,17)/t7-,10-,11-,14-/m1/s1

Standard InChI Key:  ITDRXDTWCNITTA-FRJWGUMJSA-N

Molfile:  

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   12.8219  -18.3868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8207  -19.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5288  -19.6153    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5270  -17.9779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2356  -18.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2404  -19.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0248  -19.4561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0170  -18.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5030  -18.7846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2812  -18.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2762  -17.7065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4949  -17.4581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2869  -20.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8117  -20.8984    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2971  -21.5558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0724  -21.2973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0659  -20.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2375  -16.6825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0505  -22.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2525  -22.5110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7372  -21.7725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7233  -19.9947    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5246  -17.1607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 13  7  1  1
 12 18  1  0
 15 19  1  1
 19 20  1  0
 16 21  1  6
 17 22  1  6
  4 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4556165

    ---

Associated Targets(Human)

HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa S3 (477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADK Tchem Adenosine kinase (1481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human orthopneumovirus (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B3 (1096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dengue virus type 2 (2400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 319.32Molecular Weight (Monoisotopic): 319.1281AlogP: -0.88#Rotatable Bonds: 2
Polar Surface Area: 131.58Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.45CX Basic pKa: 6.15CX LogP: -0.93CX LogD: -0.95
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.48Np Likeness Score: 0.70

References

1. Tokarenko A, Lišková B, Smoleń S, Táborská N, Tichý M, Gurská S, Perlíková P, Frydrych I, Tloušt'ová E, Znojek P, Mertlíková-Kaiserová H, Poštová Slavětínská L, Pohl R, Klepetářová B, Khalid NU, Wenren Y, Laposa RR, Džubák P, Hajdúch M, Hocek M..  (2018)  Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides.,  61  (20): [PMID:30281308] [10.1021/acs.jmedchem.8b01258]

Source